Antenna Foundation, Geneva, Switzerland.
Jordan Red Crescent, Amman, Jordan.
J Altern Complement Med. 2019 Dec;25(12):1200-1205. doi: 10.1089/acm.2019.0220. Epub 2019 Oct 10.
To assess the use of (HS), known as karkade in Jordan, in cases of uncontrolled hypertension, either with or without medication, as validated by several clinical trials. A multicentric pilot clinical study. Outside a refugee camp in Jordan. Thirty-eight participants with blood pressure (BP) above 140/90 mmHg consumed tea. Consumption of karkade tea containing 10 g of HS/0.5 L daily. This dosage was increased to 15 g of HS/1 L and to 20 g of HS/1 L during the second and third weeks, respectively, if their BP was still high. The primary outcome measurement was blood measurement taken once a week. Secondary outcome measurements were satisfaction, possible side effects, and interactions with other medications. Of the 38 participants, 29 finished the program, 72% of whom were taking antihypertensive medication due to uncontrolled hypertension and 28% of whom were not. was generally well tolerated: 38% of participants reached the target BP at the end of the study and 65% saw their systolic BP decrease by at least 10 mmHg. (karkade) is generally well tolerated and seems to be helpful in treating uncontrolled hypertension, with or without medication.
评估 HS（在约旦被称为卡考德）在未经药物治疗或联合药物治疗的情况下控制高血压的使用情况，这已被多项临床试验证实。一项多中心试点临床研究。在约旦的一个难民营外。38 名血压（BP）高于 140/90mmHg 的参与者饮用 茶。每天饮用含有 10g HS/0.5L 的卡考德茶。如果他们的血压仍然很高，第二和第三周分别将 HS 剂量增加到 15g/1L 和 20g/1L。主要结局测量是每周测量一次血。次要结局测量是满意度、可能的副作用以及与其他药物的相互作用。在 38 名参与者中，有 29 名完成了该方案，其中 72%因高血压未控制而正在服用抗高血压药物，28%未服用。通常耐受性良好：38%的参与者在研究结束时达到目标血压，65%的患者收缩压至少下降了 10mmHg。（卡考德）通常耐受性良好，似乎有助于治疗未经药物治疗或联合药物治疗的未控制高血压。
